The cannabis industry is dominated by the big four companies and these companies have emerged as the industry leaders. They benefit from factors including access to the lowest cost of institutional capital, scale, proven management talent, track records, strong balance sheets, and licensing credibility. [more]
This past quarter, Canadian cannabis companies focused on consolidating operations, adjusting asset valuations, and launching Cannabis 2.0 derivative products. While in the U.S., cannabis companies increased production capacity and scaled retail stores in order to be ready when federal legalization of cannabis becomes a reality. [more]
Only 6 pure-play, non-penny cannabis stocks are higher year-to-date out of a total of 300 actively traded cannabis stocks listed on the various North American stock exchanges. The 6 stocks are up 7.4% YTD on average. [more]
298 cannabis stocks trade on N.A. stock exchanges and are down 25.9% YTD. Lorimer Wilson from MunKNEE.com highlights the performance of the 12 “momentum” stocks within the Non-penny Pot Stock Index that are all up this year. [more]
Canopy Growth, the largest cannabis company in the world based on market cap, reported full year earnings for F2020, with a 73% increase in revenue year-over-year, however, its bottom line reached over C$1 billion in losses due to restructuring initiatives, costing upwards of C$700 million. [more]
As the coronavirus negatively affects the business world and companies cut or pull guidance, here are three companies, backed by recently released financial results, which have reaffirmed growth guidance for 2020 – Sangoma, Trulieve and Xebec. [more]
Copyright © 2025 | MH Magazine WordPress Theme by MH Themes